POTS common in patients with long COVID
A new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those… read more.
A new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those… read more.
Children and adolescents are at a significantly higher risk of various SARS-CoV-2 infection (PASC/long COVID) outcomes after reinfection with SARS-CoV-2, researchers reported in Lancet Infectious Diseases on September… read more.
Millions of people around the world are suffering with the serious cardiovascular effects of Covid infection and long Covid. A lack of clear guidance on how to reduce… read more.
New research by Edith Cowan University (ECU) Centre of Precision Health visiting PhD scholar Ms Debora Barbosa Ronca found that people with excess weight are more likely to… read more.
Long COVID can result in increased risk for a variety of serious health problems for young people, including those affecting the kidney, gut, and cardiovascular system, according to… read more.
Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with… read more.
An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long… read more.
Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL (University College London) researchers. The study,… read more.
Nearly one in 10 people who get COVID while pregnant will go on to develop long COVID, a report publishing July 11th in Obstetrics & Gynecology has found. “It was surprising to… read more.
To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just… read more.
AIM ImmunoTech Inc. announced positive topline results from the Company’s Phase II study evaluating the efficacy and safety of Ampligen as a potential therapeutic for people with the… read more.
Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling… read more.